STOCK TITAN

Senseonics Holdings, Inc. to Participate in Upcoming Conferences

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

Senseonics Holdings, Inc. (NYSE American: SENS) will be participating in two upcoming conferences: the RBC Capital Markets Global Healthcare Conference and the H.C. Wainwright 2nd Annual BioConnect Investor Conference in New York, NY. Management will engage in one-on-one meetings at both events, with the RBC conference scheduled for May 15, 2024, and the H.C. Wainwright conference on May 20, 2024. A live and recorded webcast of the presentation will be available on the 'Investor Relations' section of the company's website.

Positive
  • None.
Negative
  • None.

GERMANTOWN, Md.--(BUSINESS WIRE)-- Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucose monitoring (CGM) systems for people with diabetes, today announced plans to participate in the upcoming RBC Capital Markets Global Healthcare Conference and the H.C. Wainwright 2nd Annual BioConnect Investor Conference, being held in New York, NY.

Management is scheduled to participate in the RBC Capital Markets Global Healthcare Conference on Wednesday, May 15, 2024, at 3:35pm ET and will hold one-on-one meetings.

Management is scheduled to participate in the H.C. Wainwright 2nd Annual BioConnect Investor Conference on Monday, May 20, 2024, at 4:00pm ET and will hold one-on-one meetings.

Interested parties may access a live and recorded webcast of the presentation on the “Investor Relations” section of the company’s website at www.senseonics.com.

About Senseonics

Senseonics Holdings, Inc. (“Senseonics”) is a medical technology company focused on the development and manufacturing of glucose monitoring products designed to transform lives in the global diabetes community with differentiated, long-term implantable glucose management technology. Senseonics’ CGM system Eversense® E3 includes a small sensor inserted completely under the skin that communicates with a smart transmitter worn over the sensor. The glucose data are automatically sent every 5 minutes to a mobile app on the user’s smartphone.

Senseonics Investor Contact

Philip Taylor

Gilmartin Group

415-937-5406

Investors@senseonics.com

Source: Senseonics Holdings, Inc.

FAQ

What conferences is Senseonics Holdings, Inc. participating in?

Senseonics Holdings, Inc. will be participating in the RBC Capital Markets Global Healthcare Conference and the H.C. Wainwright 2nd Annual BioConnect Investor Conference in New York, NY.

When is the RBC Capital Markets Global Healthcare Conference?

The RBC Capital Markets Global Healthcare Conference is scheduled for May 15, 2024.

When is the H.C. Wainwright 2nd Annual BioConnect Investor Conference?

The H.C. Wainwright 2nd Annual BioConnect Investor Conference is scheduled for May 20, 2024.

Where can interested parties access the webcast of the presentation?

Interested parties can access the live and recorded webcast of the presentation on the 'Investor Relations' section of Senseonics Holdings, Inc.'s website at www.senseonics.com.

Senseonics Holdings, Inc.

NYSE:SENS

SENS Rankings

SENS Latest News

SENS Stock Data

287.78M
563.15M
4.86%
10.01%
6.64%
Medical Devices
Industrial Instruments for Measurement, Display, and Control
Link
United States of America
GERMANTOWN